Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEACE V (STORM): Salvage Treatment for Oligorecurrent Nodal Prostate Cancer
NCT03569241Phase 2Active, not recruiting
- Sponsor
- Ghent University Hospital
- Start
- Apr 2018
- Primary completion
- Apr 2023
- Countries
- 6
01
Overview
Phase 2, randomised, open-label trial in prostate cancer (PCa) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Metastasis-Free Survival at 2 years. Started Apr 2018; status: active, not recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03569241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03569241.